Ethanol → HCID 137194576, compound

HRID 731255Notes

Reaction equation

HRID 731255 reaction equation
[CH3:1][S:2]([NH:5][C:6]1[CH:21]=[CH:20][C:9]2[NH:10][C:11]([CH2:16][C:17](O)=[O:18])=[N:12][S:13](=[O:15])(=[O:14])[C:8]=2[CH:7]=1)(=[O:4])=[O:3].C(O[C:25]([CH:27]1[CH2:31][CH2:30][CH2:29][CH:28]1[NH:32][CH2:33][C:34]1[CH:39]=[CH:38][CH:37]=[C:36]([F:40])[CH:35]=1)=[O:26])C.CN1CCOCC1.Cl.CN(C)CCCN=C=NCC.[O-]CC.[Na+].C(O)C>CN(C)C=O.C(O)(=O)C>[F:40][C:36]1[CH:35]=[C:34]([CH:39]=[CH:38][CH:37]=1)[CH2:33][N:32]1[C@@H:28]2[C@@H:27]([CH2:31][CH2:30][CH2:29]2)[C:25]([OH:26])=[C:16]([C:11]2[NH:10][C:9]3[CH:20]=[CH:21][C:6]([NH:5][S:2]([CH3:1])(=[O:4])=[O:3])=[CH:7][C:8]=3[S:13](=[O:14])(=[O:15])[N:12]=2)[C:17]1=[O:18]

Participants

9

Conditions

Temperature
25 °C

Procedure

A solution of (7-methanesulfonylamino-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-3-yl)-acetic acid (prepared as described in Example 1j, 0.100 g, 0.300 mmol) and 2-(3-fluoro-benzylamino)-cyclopentanecarboxylic acid ethyl ester (0.080 g, 0.300 mmol) in N,N-dimethylformamide (1.5 mL) was treated with N-methylmorpholine (63.7 mg, 0.63 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (60.4 mg, 0.315 mmol) and stirred at 25° C. for 4 h. The solvent was removed in vacuo. The crude material was redissolved in ethyl acetate (75 mL) and washed twice with 1.0 M aqueous hydrochloric acid solution (50 mL). The organic layer was then dried over sodium sulfate, filtered and concentrated in vacuo. The crude intermediate was redissolved in ethanol (5 mL) and treated with a 21% w/w solution of sodium ethoxide in ethanol (448 μL, 1.2 mmol) and stirred for 2 h at 60° C. The reaction was allowed to cool to 25° C., treated with glacial acetic acid (0.4 mL), the solvents were removed in vacuo, and the residue was purified by prep-HPLC [Column Luna 5μ C18 (2) 100 Å AXIA 50×21.2 mm, 5 micron, 30%-90% in 7 min @ 30 mL/min flow rate, 0.05% trifluoroacetic acid in acetonitrile/0.05% trifluoroacetic acid in water] to afford the desired product, cis-N-{3-[1-(3-fluoro-benzyl)-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-[1]pyrindin-3-yl]-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide (50.9 mg, 0.095 mmol, 31.7%), as a white solid. 1H NMR (400 MHz, DMSO-d6) δ: 1.46-1.62 (3H, m), 1.97-2.19 (3H, m), 3.06 (3H, s), 3.86-3.93 (1H, m), 4.46-4.55 (1H, m), 4.94 (1H, d, J=15.6 Hz), 7.07-7.12 (1H, m), 7.18-7.20 (2H, m), 7.35-7.41 (1H, m), 7.50-7.53 (1H, m), 7.58-7.60 (2H, m), 10.18 (1H, s). LC-MS (ESI) calcd for C23H23FN4O6S2 534.10, found 535.4 [M+H+].

Workup

  1. customThe solvent was removed in vacuo
  2. dissolutionThe crude material was redissolved in ethyl acetate (75 mL)
  3. washwashed twice with 1.0 M aqueous hydrochloric acid solution (50 mL)
  4. dry with materialThe organic layer was then dried over sodium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated in vacuo
  7. dissolutionThe crude intermediate was redissolved in ethanol (5 mL)
  8. stirringstirred for 2 h at 60° C
  9. temperatureto cool to 25° C.
  10. customthe solvents were removed in vacuo
  11. customthe residue was purified by prep-HPLC [Column Luna 5μ C18 (2) 100 Å AXIA 50×21.2 mm, 5 micron, 30%-90% in 7 min

Sources & evidence

ORD record
ord-bf3ff2fc343c48749bcd19ada9b68f84
Source dataset
uspto-grants-2009_09
Patent number
US07582626B2

Reaction notes

Loading…